Learning Objectives:

1. Appreciate subclinical disease and relevance of early diagnosis.

2. Recognize most important determinants of morbidity and mortality.

3. Appreciate emerging targeted therapies with "disease modifying" potential for vascular disease and fibrosis.

Session date: 
Tuesday, April 20, 2021 - 8:30am to 9:30am
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Francesco Boin, M.D.